Cong Chen
Fujian University of Traditional Chinese Medicine(CN)Fujian Medical University(CN)Central South University(CN)National Clinical Research(US)Second Affiliated Hospital of Zhejiang University(CN)Xiangya Hospital Central South University(CN)Union Hospital(CN)
Publications by Year
Research Areas
Cancer Immunotherapy and Biomarkers, Reproductive System and Pregnancy, Immunotherapy and Immune Responses, Endometriosis Research and Treatment, Immune Cell Function and Interaction
Most-Cited Works
- → Phase IIB Multicenter Trial of Vorinostat in Patients With Persistent, Progressive, or Treatment Refractory Cutaneous T-Cell Lymphoma(2007)1,038 cited
- → Phase I Study of Pembrolizumab (MK-3475; Anti–PD-1 Monoclonal Antibody) in Patients with Advanced Solid Tumors(2015)774 cited
- → The impact of serum uric acid on cardiovascular outcomes in the LIFE study(2004)475 cited
- → Phase I Pharmacologic and Pharmacodynamic Study of the Gamma Secretase (Notch) Inhibitor MK-0752 in Adult Patients With Advanced Solid Tumors(2012)314 cited
- → Tumor-Associated Macrophages Regulate Murine Breast Cancer Stem Cells Through a Novel Paracrine EGFR/Stat3/Sox-2 Signaling Pathway(2012)298 cited
- → Naringenin attenuates non‐alcoholic fatty liver disease by down‐regulating the NLRP3/NF‐κB pathway in mice(2019)277 cited